Dewpoint Therapeutics GmbH
 | |
| Branche: | Biotechnology |
| Produkte/Dienstleistungen: | Condensate drug discovery and development |
| Standort(e): | Frankfurt, Dresden, Boston |
| Gründungsdatum: | 2018 |
| Mitarbeiterzahl: | 150 |
| Das Unternehmen: | Dewpoint is the first company to apply the emerging understanding of biomolecular condensates to drug discovery. Dewpoint develops drugs for the vast range of conditions that are regulated by condensates or arise from the dysfunction of condensates. Dewpoint currently has programs across an ambitious pipeline spanning oncology, neurodegenerative, cardiopulmonary and virology indications, and collaborations with leading global academic and pharmaceutical partners, including Bayer, Merck and Pfizer. Dewpoint scientists work to translate condensate biology into breakthrough treatments for diseases previously considered untreatable. |
| Angebotene Stellen pro Jahr: | 20 |
| Gesuchte Fachrichtungen: | Biochemistry, biological sciences, biotechnology, chemistry, informatics |
| Weitere gesuchte Fachrichtungen: | Bioinformatics |
| Gesuchte Abschlüsse: | PostDoc, PhD, master, students |
| Zusatzqualifikationen (soft skills): | Ability to communicate effectively in English, the shared language of our multicultural team |
| Einstiegsmöglichkeiten: | Direct entry & Internships |
| Traineeprogramme (Zahl der Plätze /Jahr): | Yes (2) |
| Kontakt: | https://dewpointx.com/join-us/ |
